Abstract:
The small bowel (SB) is the most common source of blood loss in patients with obscure gastrointestinal bleeding (OGIB). Without specific therapy 60-75% of patients with OGIB experience continued GI blood loss. The rate of recurrent OGIB after double balloon enteroscopy (DBE) has been reported to be 40% at 30 months of follow up. The impact of single balloon enteroscopy (SBE) on the long-term outcomes of patients with OGIB has not been established.
Citation:
Kushnir, V. M., Tang, M., Hollander, T. G., Hovis, C. E., Early, D. S., Mullady, D., ... & Chen, C. H. (2012). Long-Term Outcomes After Single Balloon Enteroscopy in Patients With Obscure Gastrointestinal Bleeding. Gastrointestinal Endoscopy, 75(4), AB251.